Radboud Repository
→
Collections Radboud University
→
Academic publications
→
Browsing Academic publications by Faculty & Departments

Browse by Faculty & Departments

Now showing items 1-50 of 1416

X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations
Campagna, D.R.; Bie, C.I. De; Schmitz-Abe, K.; Sweeney, M.; Sendamarai, A.K.; Schmidt, P.J.; Heeney, M.M.; Yntema, H.G. ; Kannengiesser, C.; Grandchamp, B.; Niemeyer, C.M.; Knoers, N.V.A.M. ; Swart, S.; Marron, G.; Wijk, R. van; Raymakers, R.A.P. ; May, A.; Markianos, K.; Bottomley, S.S.; Swinkels, D.W. ; Fleming, M.D. et al. sine al.
2014, Article / Letter to editor (American Journal of Hematology, vol. 89, iss. 3, (2014), pp. 315-319)
X-linked sideroblastic anaemia due to ALAS(2) mutations in the Netherlands: a disease in disguise
Donker, A.E.; Raymakers, R.A.P. ; Nieuwenhuis, H.K.; Coenen, M.J.H. ; Janssen, M.C.H. ; MacKenzie, M.A. ; Brons, P.P.T. ; Swinkels, D.W.
2014, Article / Letter to editor (Netherlands Journal of Medicine, vol. 72, iss. 4, (2014), pp. 210-217)
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
Schrezenmeier, H.; Passweg, J.R.; Marsh, J.C.; Bacigalupo, A.; Bredeson, C.N.; Bullorsky, E.; Camitta, B.M.; Champlin, R.E.; Gale, R.P.; Fuhrer, M.; Klein, J.P.; Locasciulli, A.; Oneto, R.; Schattenberg, A.V.M.B. ; Socie, G.; Eapen, M. et al. sine al.
2007, Article / Letter to editor (Blood, vol. 110, iss. 4, (2007), pp. 1397-1400)
Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients
Verweij, P.E. ; Voss, A. ; Donnelly, J.P. ; Pauw, B.E. de ; Meis, J.F.G.M.
1997, Article / Letter to editor (Journal of Clinical Microbiology, vol. 35, iss. 9, (1997), pp. 2422-2423)
WiN Study Group: CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders, Y.V.; Bom, J.G. Van Der; Isaacs, A.; Cnossen, M.H.; Maat, M.P. de; Laros-van Gorkom, B.A.P. ; Fijnvandraat, K.; Meijer, K.; Duijn, C.M. van; Mauser-Bunschoten, E.P. ; Eikenboom, J.; Leebeek, F.W.; Brons, P.P. ; et al. et al. sine al.
2015, Article / Letter to editor (Journal of Thrombosis and Haemostasis, vol. 13, (2015), pp. 956-966)
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
Lesterhuis, W.J. ; Schreibelt, G. ; Scharenborg, N.M. ; Brouwer, H.M.; Gerritsen, M.J.P. ; Croockewit, S. ; Coulie, P.G.; Torensma, R. ; Adema, G.J. ; Figdor, C.G. ; Vries, I.J.M. de ; Punt, C.J.A. et al. sine al.
2011, Article / Letter to editor (Cancer Immunology Immunotherapy, vol. 60, iss. 2, (2011), pp. 249-260)
Wijzigingen in de richtlijn ‘Behandeling multipel myeloom 2018’
Zweegman, S.; Donk, N.W. van de; Levin, M.-D.; Bos, G.M.; Ypma, P.; Waal, E. de; Kersten, M.J.; Croockewit, A.J. ; Choi, C.W.; Klein, S.K.; Borne, P.A. von dem; Broyl, A.; Nijhof, I.; Minnema, M.C.; Sonneveld, P. et al. sine al.
2018, Article / Letter to editor (Nederlands Tijdschrift voor Hematologie, vol. 15, iss. 3, (2018), pp. 108-114)
Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis
Saes, J.L.; Simons, A. ; Munnik, S.A. de ; Nijziel, M.R.; Blijlevens, N.M.A. ; Jongmans, M.C. ; Reijden, B.A. van der ; Brons, P.P. ; Heerde, W.L. van ; Schols, S.E.M.
2019, Article / Letter to editor (Haemophilia, vol. 25, iss. 1, (2019), pp. 127-135)
Which physiological mechanism is responsible for the increase in blood pressure during leg crossing?
Groningen, L.F.J. van; Adiyaman, A.; Elving, L.D. ; Thien, Th. ; Lenders, J.W.M. ; Deinum, J.
2008, Article / Letter to editor (Journal of Hypertension, vol. 26, iss. 3, (2008), pp. 433-437)
Which myelodysplastic syndromes patients are candidates for transplantation?
Witte, T.J.M. de ; Biezen, A. van ; Brand, R.; Suciu, S.; Kroger, N.
2007, Article / Letter to editor (Leukemia Research, vol. 31, iss. 1, (2007), pp. S21-22)
Vragen rond aanvullende radiotherapie bij patiënten met de ziekte van Hodgkin stadium III of IV, in remissie na chemotherapie
Raemaekers, J.M.M.
1997, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 141, iss. 26, (1997), pp. 1285-1289)
Vragen rond aanvullende radiotherapie bij patienten met de ziekte van Hodgkin stadium III of IV, in remissie na chemotherapie
Raemaekers, J.M.M.
1997, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 141, iss. 26, (1997), pp. 1285-1289)
Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
Donnelly, J.P. ; Pauw, B.E. de
2004, Article / Letter to editor (Clinical Microbiology and Infection, vol. 10 Suppl 1, iss. suppl. 1, (2004), pp. 107-117)
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study
Lestrade, P.P. ; Bentvelsen, R.G.; Schauwvlieghe, A.; Schalekamp, S.; Velden, W.J.F.M. van der ; Kuiper, E.J.; Paassen, J. van; Hoven, B. van der; Lee, H.A.L. van der; Melchers, W.J.G. ; Haan, A.F. de; Hoeven, H. van der ; Rijnders, B.J.A.; Beek, M.T. van der; Verweij, P.E. et al. sine al.
2019, Article / Letter to editor (Clinical Infectious Diseases, vol. 68, iss. 9, (2019), pp. 1463-1471)
von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
Sanders, Y.V.; Groeneveld, D.; Meijer, K.; Fijnvandraat, K.; Cnossen, M.H.; Bom, J.G. Van Der; Coppens, M.; Meris, J. de; Laros-van Gorkom, B.A. ; Mauser-Bunschoten, E.P. ; Leebeek, F.W.; Eikenboom, J.; Brons, P.P.T. ; et al. et al. sine al.
2015, Article / Letter to editor (Blood, vol. 125, iss. 19, (2015), pp. 3006-3013)
[Von Willebrand disease in the Netherlands: the WiN study]
Sanders, Y.V.; Wee, E.M. de; Meijer, K.; Eikenboom, J.; Bom, J.G. Van Der; Fijnvandraat, C.J.; Laros, B.A.P. ; Cnossen, M.H.; Mauser-Bunschoten, E.P. ; Leebeek, F.W.
2014, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 158, (2014), pp. A6518)
von Willebrand disease and aging: an evolving phenotype
Sanders, Y.V.; Giezenaar, M.A.; Laros, B.A.P. ; Meijer, K.; Bom, J.G. Van Der; Cnossen, M.H.; Nijziel, M.R.; Ypma, P.F.; Fijnvandraat, K.; Eikenboom, J.; Mauser-Bunschoten, E.P. ; Leebeek, F.W.; Wi, N.s.g. et al. sine al.
2014, Article / Letter to editor (Journal of Thrombosis and Haemostasis, vol. 12, iss. 7, (2014), pp. 1066-1075)
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
Segeren, C.M.; Sonneveld, P.; Holt, B. van der; Baars, J.W.; Biesma, D.H.; Cornelissen, J.J.L.M. ; Croockewit, A.J. ; Dekker, A.W.; Fibbe, W.; Marwijk-Kooy, M. van; Lowenberg, B.; Oers, R.H.J. van; Richel, D.J.; Schouten, H.C.; Vellenga, E.; Verhoef, G.E.; Wijermans, P.W.; Wittebol, S.; Lokhorst, H.M. et al. sine al.
1999, Article / Letter to editor (British Journal of Haematology, iss. 105, (1999), pp. 127-130)
Verpleegkundige aandachtspunten bij beenmergtransplantatie
Verhoeven, M.J.F.W.; Bremmers, M.E.J. ; Nelissen, R.
1995, Article / Letter to editor
[Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use]
Berends, M. ; Bokhoven, M.M. van; Luijtgaarden, A.C.M. van de ; Bellersen, L. ; Hoesel, Q.G.C.M. van ; Herpen, C.M.L. van
2008, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 152, iss. 38, (2008), pp. 2088-2092)
Variation in guideline adherence in non-Hodgkin's lymphoma care: impact of patient and hospital characteristics
Stienen, J.J.C.; Hermens, R.P.M.G. ; Wennekes, L.; Schans, S.A. van de; Maazen, R.W.M. van der ; Dekker, H.M. ; Liefers, J. ; Krieken, J.H.J.M. van ; Blijlevens, N.M.A. ; Ottevanger, P.B.
2015, Article / Letter to editor (BMC Cancer, vol. 15, (2015), article 578)
Value of infliximab (Remicade(R)) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group.
Baron, F.; Suciu, S.; Amadori, S.; Muus, P. ; Zwierzina, H.; Denzlinger, C.; Delforge, M.; Thyss, A.; Selleslag, D.; Indrak, K.; Ossenkoppele, G.; Witte, T.J. de et al. sine al.
2012, Article / Letter to editor (Haematologica, vol. 97, iss. 4, (2012), pp. 529-533)
The value of FDG-PET CT scans to evaluate bone marrow in haemato-oncological conditions
Son, P.M. van; Evers, D.; Aarntzen, E.H.J.G.
2019, Article / Letter to editor (Netherlands Journal of Medicine, vol. 77, iss. 7, (2019), pp. 234-242)
Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy.
Lunel, F.M.; Mennink-Kersten, M.A.S.H.; Ruegebrink, D. ; Lee, H.A.L. van der; Donnelly, J.P. ; Blijlevens, N.M.A. ; Verweij, P.E.
2009, Article / Letter to editor (Diagnostic Microbiology and Infectious Diseases, vol. 64, iss. 4, (2009), pp. 408-415)
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.
Witte, T.J.M. de ; Hagemeijer, A.; Suciu, S.; Belhabri, A.; Delforge, M.; Kobbe, G.; Selleslag, D.; Schouten, H.C.; Ferrant, A.; Biersack, H.; Amadori, S.; Muus, P. ; Jansen, J.H. ; Hellstrom-Lindberg, E.; Kovacsovics, T.; Wijermans, P.; Ossenkoppele, G.; Gratwohl, A.; Marie, J.P.; Willemze, R. et al. sine al.
2010, Article / Letter to editor (Haematologica, vol. 95, iss. 10, (2010), pp. 1754-1761)
Validation, revision and extension of the Mantle Cell Lymphoma International Prognostic Index in a population-based setting.
Schans, S.A. van de; Janssen-Heijnen, M.L.; Nijziel, M.R.; Steyerberg, E.W.; Spronsen, D.J. van
2010, Article / Letter to editor (Haematologica, vol. 95, iss. 9, (2010), pp. 1503-1509)
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Scheid, C.; Wreede, L. de; Biezen, A. van; Koenecke, C.; Gohring, G.; Volin, L.; Maertens, J.; Finke, J.; Passweg, J.; Beelen, D.; Cornelissen, J.J.; Itala-Remes, M.; Chevallier, P.; Russell, N.; Petersen, E.; Milpied, N.; Espiga, C.R.; Peniket, A.; Sierra, J. ; Mufti, G.; Crawley, C.; Veelken, J.H.; Ljungman, P.; Cahn, J.Y.; Alessandrino, E.P.; Witte, T.J. de ; Robin, M.; Kroger, N. et al. sine al.
2017, Article / Letter to editor (Bone Marrow Transplantation, vol. 52, iss. 11, (2017), pp. 1519-1525)
Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry
Swart, L. de; Smith, A.; Johnston, T.W.; Haase, D.; Droste, J.; Fenaux, P.; Symeonidis, A.; Sanz, G.; Hellstrom-Lindberg, E.; Cermak, J.; Germing, U.; Stauder, R.; Georgescu, O.; MacKenzie, M.; Malcovati, L.; Holm, M.S.; Almeida, A.M.; Madry, K.; Slama, B.; Guerci-Bresler, A.; Sanhes, L.; Beyne-Rauzy, O.; Luno, E.; Bowen, D.; Witte, T.J. de et al. sine al.
2015, Article / Letter to editor (British Journal of Haematology, vol. 170, iss. 3, (2015), pp. 372-383)
Validating PCR for detecting invasive aspergillosis.
Verweij, P.E. ; Klont, R.R.; Donnelly, J.P.
2004, Article / Letter to editor (British Journal of Haematology, vol. 127, iss. 2, (2004), pp. 235-236)
Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
Aarntzen, E.H.J.G. ; Schreibelt, G. ; Bol, K.F. ; Lesterhuis, W.J. ; Croockewit, A.J. ; Wilt, J.H. de ; Rossum, M.M. van ; Blokx, W.A.M. ; Jacobs, J.F.M. ; Duiveman-de Boer, T. ; Schuurhuis, D.H.; Mus, R.D. ; Thielemans, K.; Vries, I.J.M. de ; Figdor, C.G. ; Punt, C.J.A. ; Adema, G.J. et al. sine al.
2012, Article / Letter to editor (Clinical Cancer Research, vol. 18, iss. 19, (2012), pp. 5460-5470)
Utility of zinc protoporphyrin in management of whole blood donors
Schotten, N; Zalpuri, Saurabh; Pasker-de Jong, Pieternel C. M.; Swinkels, D.W. ; Hurk, Katja van den; Kort, W.L. de; Kraaij, Marian G.J. van ; Noord, P.A.H. van
2018, Article / Letter to editor (Transfusion, vol. 58, iss. 3, (2018), pp. 692-700)
Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors
Loo, L. van de; Berg, M.H. van den; Overbeek, A.; Dijk, M van; Damen, L.; Lambalk, C.B.; Ronckers, C.M.; Heuvel-Eibrink, M.M. van den; Kremer, L.C.; Pal, H.J. van der; Laven, J.S.; Tissing, W.J.; Loonen, J.J. ; Versluys, B.; Bresters, D.; Kaspers, G.J.; Leeuwen, F.E. van; Broeder, E. van Dulmen-den et al. sine al.
2019, Article / Letter to editor (Fertility and Sterility, vol. 111, iss. 2, (2019), pp. 372-380)
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease
Keller, M.F.; Saad, M.; Bras, J.; Bettella, F.; Nicolaou, N.; Simon-Sanchez, J.; Mittag, F.; Buchel, F.; Sharma, M.; Gibbs, J.R.; Schulte, C.; Moskvina, V.; Durr, A.; Holmans, P.; Kilarski, L.L.; Guerreiro, R.; Hernandez, D.G.; Brice, A.; Ylikotila, P.; Stefansson, H.; Majamaa, K.; Morris, H.R.; Williams, N.; Gasser, T.; Heutink, P.; Wood, N.W.; Hardy, J.; Martinez, M.; Singleton, A.B.; Nalls, M.A.; Donnelly, P. ; Bloem, B. ; et al. et al. sine al.
2012, Article / Letter to editor (Human Molecular Genetics, vol. 21, iss. 22, (2012), pp. 4996-5009)
Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.
Hoogen, M.W.F. van den ; Verbruggen, H.W. ; Polenewen, R.; Hilbrands, L.B. ; Novakova, I.R.O.
2009, Article / Letter to editor (Thrombosis Research, vol. 123, iss. 3, (2009), pp. 515-522)
Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)
Lowenberg, B.; Suciu, S.; Archimbaud, E.; Ossenkoppele, G.J. ; Verhoef, G.E.G.; Vellenga, E.; Wijermans, P.; Berneman, Z.; Dekker, A.W.; Stryckmans, P.; Schouten, H.C.; Jehn, U.; Muus, P. ; Sonneveld, P.; Dardenne, M.; Zittoun, R. et al. sine al.
1997, Article / Letter to editor (Blood, vol. 90, iss. 8, (1997), pp. 2952-2961)
Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)
Lowenberg, B.; Suciu, S.; Archimbaud, E.; Ossenkoppele, G.J.; Verhoef, G.E.; Vellenga, E.; Wijermans, P.W.; Berneman, Z.; Dekker, A.W.; Stryckmans, P.; Schouten, H.C.; Jehn, U.; Muus, P. ; Sonneveld, P.; Dardenne, M.; Zittoun, R. et al. sine al.
1997, Article / Letter to editor (Blood, vol. 90, iss. 8, (1997), pp. 2952-2961)
Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.
Slappendel, R.; Huvers, F.C. ; Benraad, B.; Nováková, I.R.O. ; Hellemondt, G. van
2002, Article / Letter to editor (Anesthesiology, vol. 96, iss. 6, (2002), pp. 1525-1527)
Use of Recombinant Activated Factor VII in patients with sever coagulopathy and bleeding.
Slappendel, R.; Huvers, F.C. ; Benraad, B.; Nováková, I.R.O. ; Hellemondt, G. van
2003, Article / Letter to editor (Anesthesiology, vol. 98, (2003), pp. 1027)
Use of Plerixafor in patients that show failure of peripheral blood stem cell mobilization with G-CSF. Experience of three Dutch centers.
Bilgin, Y.M.; Gahar, R.R.; Visser, O; Croockewit, A.J. ; Greef, G.E. de
2013, Article / Letter to editor (Transfusion and Apheresis Science, vol. 48, iss. 2, (2013)-191)
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis.
Mengoli, C.; Cruciani, M.; Barnes, R.A.; Loeffler, J.; Donnelly, J.P.
2009, Article / Letter to editor (Lancet Infectious Diseases, vol. 9, iss. 2, (2009), pp. 89-96)
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
Stahl, M.; DeVeaux, M.; Witte, T.J. de ; Neukirchen, J.; Sekeres, M.A.; Brunner, A.M.; Roboz, G.J.; Steensma, D.P.; Bhatt, V.R.; Platzbecker, U.; Cluzeau, T.; Prata, P.H.; Itzykson, R.; Fenaux, P.; Fathi, A.T.; Smith, A.; Germing, U.; Ritchie, E.K.; Verma, V.; Nazha, A.; Maciejewski, J.P.; Podoltsev, N.A.; Prebet, T.; Santini, V.; Gore, S.D.; Komrokji, R.S.; Zeidan, A.M. et al. sine al.
2018, Article / Letter to editor (Blood Advances, vol. 2, iss. 14, (2018), pp. 1765-1772)
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.
Amadori, S.; Suciu, S.; Jehn, U.; Stasi, R.; Thomas, X.; Marie, J.P.; Muus, P. ; Lefrere, F.; Berneman, Z.; Fillet, G.; Denzlinger, C.; Willemze, R.; Leoni, P.; Leone, G.; Casini, M.; Ricciuti, F.; Vignetti, M.; Beeldens, F.; Mandelli, F.; Witte, T.J.M. de et al. sine al.
2005, Article / Letter to editor (Blood, vol. 106, iss. 1, (2005), pp. 27-34)
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
Czerw, T.; Labopin, M. ; Gorin, N.C. ; Giebel, S.; Blaise, D.; Dumas, P.Y.; Foa, R.; Attal, M.; Schaap, N.P. ; Michallet, M. ; Bonmati, C.; Veelken, H.; Mohty, M. et al. sine al.
2014, Article / Letter to editor (Bone Marrow Transplantation, vol. 49, iss. 7, (2014), pp. 950-954)
The use of counterflow centrifugation elutriation (CCE) to deplete T cells from allogeneic peripheral blood stem cell grafts
Preijers, F.W.M.B. ; Schattenberg, A.V.M.B. ; Ruijs, P.; Witte, T.J.M. de
1997, Article / Letter to editor (Journal of Hematotherapy, vol. 6, (1997), pp. 407)
The use of counterflow centrifugation elutriation (CCE) to deplete T cells from allogeneic peripheral blood stem cell grafts
Preijers, F.W.M.B. ; Schattenberg, A.V.M.B. ; Ruijs, P.; Witte, T.J.M. de
1997, Article / Letter to editor (Journal of Hematotherapy, vol. 6, (1997), pp. 407)
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors
Gahrton, G.; Tura, S.; Ljungman, P.; Blade, J.; Cavo, M.; Laurenzi, A.; Facon, T.; Gratwohl, A.; Michallet, M. ; Nikoskelainen, A.; Pearce, R.; Reiffers, J. ; Samson, D.; Schattenberg, A.V.M.B. ; Verdonck, L.F. ; Vernant, J.P.; Volin, L. et al. sine al.
1995, Article / Letter to editor (Stem Cells, vol. 13, iss. suppl., (1995), pp. 122-125)
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors
Gahrton, G.; Tura, S.; Ljungman, P.; Blade, J.; Cavo, M.; Laurenzi, A.; Facon, T.; Gratwohl, A.; Michallet, M. ; Nikoskelainen, A.; Pearce, R.; Reiffers, J. ; Samson, D.; Schattenberg, A.V.M.B. ; Verdonck, L.F.; Vernant, J.P.; Volin, L. et al. sine al.
1995, Article / Letter to editor (Stem Cells, vol. 13, iss. (suppl.), (1995), pp. 122-125)
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
Robin, M.; Sanz, G.F.; Ionescu, I.; Rio, B.; Sirvent, A.; Renaud, M.; Carreras, E. ; Milpied, N.; Mohty, M.; Beguin, Y.; Bordigoni, P.; Witte, T.J.M. de ; Picardi, A.; Purtill, D.; Gluckman, E.; Kroger, N.; Rocha, V. et al. sine al.
2011, Article / Letter to editor (Leukemia, vol. 25, iss. 1, (2011), pp. 75-81)
Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey
Arnold, R.; Witte, T.J.M. de ; Biezen, A. van ; Hermans, J.; Jacobsen, N.; Runde, V.; Gratwohl, A.; Apperley, J.
1998, Article / Letter to editor (Bone Marrow Transplantation, vol. 21, (1998), pp. 1213-1216)
Tyrosine kinase inhibitor levels matter in treating chronic GVHD
Wagen, L. van der; Janssen, J; Raijmakers, R.; Petersen, E.; Witte, M. de; Jong, N. de; Bellido, M.; Meijer, E.; Bar, B.M. ; Boelens, J. Jan; Huitema, A.; Kuball, J. et al. sine al.
2019, Article / Letter to editor (Bone Marrow Transplantation, vol. 54, iss. 7, (2019), pp. 1141-1144)

Now showing items 1-50 of 1416

Search Repository

Browse

All of Repository
This Collection

Radboud Repository

Browse by Faculty & Departments

Search Repository

Browse

All of Repository

This Collection